BridgeBio Pharma, Inc. Equity Repurchase (Preffered, Net)

Equity Repurchase (Preffered, Net) of BBIO for past 10 years: annual, quarterly and twelve month trailing (TTM) including Equity Repurchase (Preffered, Net) growth rates and interactive chart.


Highlights and Quick Summary

  • Equity Repurchase (Preffered, Net) for the quarter ending September 30, 2021 was $3.5 Million (a 75.0% increase compared to previous quarter)
  • Year-over-year quarterly Equity Repurchase (Preffered, Net) increased by 133.33%
  • Annual Equity Repurchase (Preffered, Net) for 2018 was $335 Million (a 213.03% increase from previous year)
  • Twelve month Equity Repurchase (Preffered, Net) ending September 30, 2021 was $8 Million
Trailing Equity Repurchase (Preffered, Net) for the last four month:
30 Sep '21
$8 Million
Visit stockrow.com/BBIO for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Equity Repurchase (Preffered, Net) of BridgeBio Pharma, Inc.

Most recent Equity Repurchase (Preffered, Net)of BBIO including historical data for past 10 years.

Interactive Chart of Equity Repurchase (Preffered, Net) of BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. Equity Repurchase (Preffered, Net) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $3.5
2020 $2.0 $1.0
2019 $1.5
2018 $335.0
2017 $107.02

Business Profile of BridgeBio Pharma, Inc.

Sector: Healthcare
Industry: Biotechnology